Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B MACH

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
Pain|August 26, 2004
Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosisMolly A Sevcik, Nancy M Luger, David B Mach, et al.
Cancer Research|December 25, 2002
Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2Mary Ann C Sabino, Joseph R Ghilardi, Joost L M Jongen, et al.
Investigational New Drugs|November 26, 2013
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumorsSharad Ghamande, Chia-Chi Lin, Daniel C Cho, et al.
Bone Marrow Transplantation|March 30, 2010
An update to HLA nomenclature, 2010S G E Marsh, E D Albert, W F Bodmer, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
Pain|August 26, 2004
Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosisMolly A Sevcik, Nancy M Luger, David B Mach, et al.
Cancer Research|December 25, 2002
Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2Mary Ann C Sabino, Joseph R Ghilardi, Joost L M Jongen, et al.
Investigational New Drugs|November 26, 2013
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumorsSharad Ghamande, Chia-Chi Lin, Daniel C Cho, et al.
Bone Marrow Transplantation|March 30, 2010
An update to HLA nomenclature, 2010S G E Marsh, E D Albert, W F Bodmer, et al.
Pageof 17